Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_925422dd1e5a8724f24c932c6bf62ec9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-86 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-86 |
filingDate |
1995-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1996-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9d5b9564e8b9f7df70e8d90fce94b2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a67487fa365e57141e9d4f4fd1ab50cc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c2887ad06914b2264d5af93bf1a8ee2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abbdc2f19bf35bd89617143f39edadc8 |
publicationDate |
1996-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5516794-A |
titleOfInvention |
Xanthone derivatives, their preparation and use |
abstract |
The novel compounds 3,6-Disubstituted xanthen-9-one of formula I <IMAGE> (I) in which R is a C3-C8 linear, branched or cyclic alkyl and R1 is linear, branched C1-C8 alkyl or cyclic C3-C8 alkyl or -OR in which R is as defined hereinabove, exhibit bone resorption inhibiting activity. Pharmaceutical compositions are described. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5741813-A |
priorityDate |
1992-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |